College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. The clinical use and laboratory monitoring of low-molecular weight heparin, danaparoid, hirudin and related compounds, and argatroban
Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. The clinical use and laboratory monitoring of low-molecular weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med 1998; 122: 799-807.
Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study
Massicotte P, Adams M, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996; 128: 313-8.
A standard heparin nomogram for management of heparin therapy
Cruickshank MK, Levine MBN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for management of heparin therapy. Arch Intern Med 1991; 151: 333-7.
Anti Xa monitoring during treatment with low-molecular-weight heparin or danaparoid: Inter-assay variability
Kitchen S, Iampietro R, Woolley AM, Preston FE. Anti Xa monitoring during treatment with low-molecular-weight heparin or danaparoid: inter-assay variability. Thromb Haemost 1999; 82: 1289-93.